{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:24:00Z","timestamp":1759332240829},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1989,5,1]],"date-time":"1989-05-01T00:00:00Z","timestamp":609984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[1989,5]]},"DOI":"10.1007\/bf00916818","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T03:38:24Z","timestamp":1104550704000},"page":"223-228","source":"Crossref","is-referenced-by-count":3,"title":["The potential usefulness of interleukin-2 activated bone marrow cells as an active therapeutic tool against cytomegalovirus infection in a bone marrow transplantation setting"],"prefix":"10.1007","volume":"9","author":[{"given":"Ravin","family":"Agah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitabha","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/infdis\/136.6.754","volume":"136","author":"PE Neiman","year":"1977","unstructured":"Neiman PE, Reeves W, Ray G, Flournoy N, Lerner KG, Sale GE, Thomas ED: A prospective analysis of interestitional pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow graft. J Infect Dis 136:754?767, 1977","journal-title":"J Infect Dis"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood.V49.4.511.511","volume":"49","author":"ED Thomas","year":"1977","unstructured":"Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden, PL: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogenic bone marrow transplantation. Blood 49:511?533, 1977","journal-title":"Blood"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1182\/blood.V59.4.844.844","volume":"59","author":"RP Witherspoon","year":"1982","unstructured":"Witherspoon RP, Lum LG, Storb R, Thomas ED:In vitro regulation of immunoglobulin synthesis after human marrow transplantation II. Deficient T and non-T lymphocytes function within 3?4 months of allogeneic syngeneic or autologous marrow grafting for hematologic malignancy. Blood 59:844?850, 1982","journal-title":"Blood"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00007890-198203000-00011","volume":"33","author":"FR Applebaum","year":"1982","unstructured":"Applebaum FR, Meyers JD, Fefer A, Flournoy N, Cheever MA, Greenberg PD, Hachman R, Thomas ED: Nonbacterial non-fungal pneumonia following transplantation in 100 identical twins. Transplantation 33:265?268, 1982","journal-title":"Transplantation"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1084\/jem.157.3.884","volume":"157","author":"EA Grimm","year":"1983","unstructured":"Grimm EA, Ramsy KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA: Lymphokine activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral I lymphocytes, memory cytotoxic thymusderived lymphocytes, and natural killer cells. J Exp Med 157:884?897, 1983","journal-title":"J Exp Med"},{"key":"CR6","first-page":"279","volume-title":"The Lymphokines, Vol 9","author":"EA Grimm","year":"1984","unstructured":"Grimm EA, Rosenberg SA: The human lymphokine-activated killer cell phenomenon.In The Lymphokines, Vol 9. Orlando, FL, Academic Press, 1984, pp 279?311"},{"key":"CR7","first-page":"4420","volume":"41","author":"MT Lotze","year":"1981","unstructured":"Lotze MT, Grimm EA, Mazumder A, Strausser JE, Rosenberg SA: Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 41:4420?4425, 1981","journal-title":"Cancer Res"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0008-8749(84)90078-9","volume":"84","author":"VJ Merluzzi","year":"1984","unstructured":"Merluzzi VJ, Savage DM, Mertelsmann R, Welte K: Generation of nonspecific murine cytotoxic T-cellsin vitro by purified human interleukin-2. Cell Immunol 84:74?84, 1984","journal-title":"Cell Immunol"},{"key":"CR9","first-page":"1946","volume":"44","author":"M Rosentein","year":"1984","unstructured":"Rosentein M, Yron I, Kaufman Y, Rosenberg SA: Lymphokine activated killer cells lysis of fresh syngeneic NK-resistant murine tumor cells by lymphocytes cultured in interleukin-2. Cancer Res 44:1946?1953, 1984","journal-title":"Cancer Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4049\/jimmunol.125.1.238","volume":"125","author":"I Yron","year":"1980","unstructured":"Yron I, Wood TA, Spiess PJ, Rosenberg SA: The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. J Immunol 125:238?245, 1980","journal-title":"J Immunol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0192-0561(85)90006-2","volume":"7","author":"VJ Merluzzi","year":"1985","unstructured":"Merluzzi VJ, Last-Barney K: Potential use of human interleukin-2 as an adjunct for the therapy of neoplasia, immunodeficiency and infectious disease. Int J Immunopharmacol 7:31?39, 1985","journal-title":"Int J Immunopharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4049\/jimmunol.134.2.926","volume":"134","author":"BT Rouse","year":"1985","unstructured":"Rouse BT, Miller LS, Turtinen L, Moore RN: Augmentation of immunity to herpes simplex virus byin vivo administration of interleukin-2. J Immunol 134:926?930, 1985","journal-title":"J Immunol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.4049\/jimmunol.135.6.4160","volume":"135","author":"SD Sharma","year":"1985","unstructured":"Sharma SD, Hofflin JM, Remington JS:In vivo recombinant interleukin-2 administration enhances survival against a lethal challenge withToxoplasma Gondii. J Immunol 135:4160?4163, 1985","journal-title":"J Immunol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0167-5699(86)90125-8","volume":"7","author":"JGP Sisson","year":"1986","unstructured":"Sisson JGP, Borysiewicz LK, Rodgers B, Scott D: Cytomegalovirus its cellular immunology and biology. Immunol Today 7:57?62, 1986","journal-title":"Immunol Today"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1128\/iai.29.2.311-315.1980","volume":"29","author":"DR Mayo","year":"1980","unstructured":"Mayo DR, Rapp F: Acute cytomegalovirus infections in leukemic mice. Infect Immun 29:311?315, 1980","journal-title":"Infect Immun"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1099\/0022-1317-37-1-107","volume":"37","author":"JE Chalmer","year":"1977","unstructured":"Chalmer JE, Mackenzie JS, Stanley NF. Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol 37:107?114, 1977","journal-title":"J Gen Virol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/IAI.35.1.5-12.1982","volume":"35","author":"GD Lee","year":"1982","unstructured":"Lee GD, Keller R: Natural cytotoxicity to murine cytomegalovirus infected cells mediated by mouse lymphoid cells; Role of interferon in the endogenous natural cytotoxicity reaction. Infect Immun 35:5?12, 1982","journal-title":"Infect Immun"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1084\/jem.159.2.495","volume":"159","author":"A Mazumder","year":"1984","unstructured":"Mazumder A, Rosenberg SA: Successful immunotherapy of natural resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activatedin vitro by interleukin-2. J Exp Med 159:495?507, 1984","journal-title":"J Exp Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.V60.1.99.99","volume":"60","author":"BA Miller","year":"1982","unstructured":"Miller BA, Siedler DA, Dunn CDR, Huang AT: Condition for anin vitro culture of murine mixed hematopoietic colonies and their putative cellular origin. Blood 60:99?107, 1982","journal-title":"Blood"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/eji.1830100304","volume":"10","author":"M Kasai","year":"1980","unstructured":"Kasai M, Iwamori M, Nagai Y, Okumura K, Tada T: A glycolipid on the surface of mouse natural killer cells. Eur J Immunol 10:175?180, 1980","journal-title":"Eur J Immunol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1084\/jem.161.1.40","volume":"161","author":"JF Buckowski","year":"1985","unstructured":"Buckowski JF, Warner I, Dennert G, Welsh RM: Adoptive transfer studies demonstrating the antiviral effect of natural killer cellsin vivo. J Exp Med 161:40?52, 1985","journal-title":"J Exp Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.4049\/jimmunol.121.5.1631","volume":"121","author":"RM Welsh","year":"1978","unstructured":"Welsh RM: Natural killer cells induction specificity and function. J Immunol 121:1631?1635, 1978","journal-title":"J Immunol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4049\/jimmunol.126.3.988","volume":"126","author":"GJ Bancroft","year":"1981","unstructured":"Bancroft GJ, Shellam GR, Chalmer JE: Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: Correlation with patterns of resistance. J Immunol 126:988?994, 1981","journal-title":"J Immunol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1073\/pnas.78.8.5104","volume":"78","author":"GR Shellam","year":"1981","unstructured":"Shellam GR, Allen JE, Papa Dimitri JM, Bancroft GT: Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci USA 78:5104?5108, 1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3181\/00379727-149-38824","volume":"149","author":"J Boos","year":"1971","unstructured":"Boos J, Wheelock EF: Correlation of survival from MCMV infection with spleen cells responsiveness to concavalin A. Proc Soc Exp Med 149:443?450, 1971","journal-title":"Proc Soc Exp Med"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00916818.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00916818\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00916818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T07:55:43Z","timestamp":1682927743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00916818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1989,5]]}},"alternative-id":["BF00916818"],"URL":"https:\/\/doi.org\/10.1007\/bf00916818","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,5]]}}}